For research use only. Not for therapeutic Use.
Cabozantinib-d4 L-Malate Salt is a deuterated form of cabozantinib, a tyrosine kinase inhibitor used in cancer treatment. In this compound, four hydrogen atoms are replaced with deuterium, which aids in detailed pharmacokinetic and metabolic studies. The L-malate salt form enhances its solubility and stability. The deuterium labeling makes it particularly useful in mass spectrometry, allowing researchers to track the drug’s behavior in the body with greater precision while retaining its therapeutic efficacy against cancer.
Catalog Number | R021202 |
CAS Number | NA |
Synonyms | N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N’-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide-d4 (2S)-2-Hydroxybutanedioic Acid; Cabozantini-d4 S-Malate; XL 184-d4; |
Molecular Formula | C₃₂H₂₆D₄FN₃O₁₀ |
Purity | ≥95% |
Storage | -80°C |